INDUSTRY STRUCTURE AND DEVELOPMENT
India has been one of the fastest growing diagnostic and pathology laboratories markets
over the past few years. Several factors that are acting as drivers for the market are
rise in spendings for health care, increasing awareness of health related concerns, high
prevalence of diseases and penetration of health care insurance.
On the basis of the tests performed by various laboratories, the overall India
diagnostic and pathology laboratory market has been segmented into radiology and pathology
tests by test type. These test types are further segmented on the basis of the type of
test and source for tests. By source of test, pathology tests have been segmented into
blood, urine, stool, and body tissue.
Also, in the developed markets, the diagnostics business is of a B2B kind. The touch
point for patients is primarily the hospitals, which in turn outsource their test
processing requirements to the laboratories. In India, the diagnostics business is of a
B2C kind, as patients here directly approach the pathology labs to get themselves tested.
At times, tests are also conducted without a doctors prescription.
BUSINESS OVERVIEW
Our Company was originally incorporated as a partnership firm at New Delhi vide
Partnership Agreement dated 15th Day of September, 2011 in the name of Dr. A Lalchandani
Pathology Laboratories. Thereafter, the Partnership Firm was taken over by Dr Lalchandani
Labs Limited incorporated under the provisions of Companies Act, 2013 vide certificate of
Incorporation dated 2nd August 2017 issued by the Registrar of Companies, Delhi vide
agreement dated 31st August 2017. The Corporate Identification Number of our Company is
L85320DL2017PLC321605.
Our Company is formed to set up, engage, collaborate, acquire, purchase, maintain, open
collection centers, conduct, manage, administer, own, run laboratories for the purposes of
carrying out pathological investigations of various branches of Bio-Chemistry, Hematology,
Histopathology, Microbiology, Electrophoresis, Virology, Cytology, other pathological
Investigations and Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA &
Genetic Testing etc.
We are a provider of diagnostic and related healthcare tests and services in Delhi/NCR.
Through our integrated network, we offer patients and healthcare providers a broad range
of diagnostic and related healthcare tests and services for use in core testing, patient
diagnosis and the prevention, monitoring and treatment of disease and other health
conditions. Our customers include individual patients, hospitals and other healthcare
providers and corporate customers.
Diagnostic healthcare testing is an essential element in the delivery of healthcare
services, as it provides healthcare service providers with useful information for the
diagnosis and treatment of diseases.
We focus on providing patients quality diagnostic and related healthcare tests and
services. We believe our focus on the patient as a customer is a critical differentiator
in the diagnostic and healthcare industries and, together with what we believe is our
brands recognition for quality diagnostic services, results in individuals and healthcare
providers choosing us as their diagnostic healthcare service provider.
Our Company, a NABL Accredited Lab has established itself within Delhi/NCR in various
self- sufficient Labs and multiple collection centers.
Our Company has its own Blood Banking services through its sister concern CPC blood
bank founded by Dr A Lalchandani himself in 1987.
Our setup at Greater Kailash-Part 1 is having technology in Diagnostics and boasts of
being aesthetically one of the most beautiful diagnostic centers in India offering
one-stop complete services such as pathology, X-ray, TMT, Ultrasound, 2D-echo, Doctor
Consultations, Medical Fitness Examinations etc.
We have recently renovated our center at Punjabi Bagh New Delhi to cater to customers
from the West Delhi region and international clients
SEGMENT-WISE AND PRODUCT-WISE PERFORMANCE PRODUCT WISE DETAILS
Since our company deals with the provision of services of a pathology lab and a
diagnostic center, this section is not applicable to our company.
OPPORTUNITIES AND THREATS OPPORTUNITIES
There are many aspects in the diagnostics industry in our country which provide huge
growth opportunity. These are-
* Corporate Health Check ups
* Consistently increasing sample load at main lab strengthens negotiation with
suppliers to give better prices for reagents improving costings and better profit margins
* Increasing B2C presence
* Lack of customer centricity in many labs
* Lack of awareness of quality parameters in consumers is an opportunity for Good Labs
like us to take charge in awareness campaigns for building good reputation with consumers.
THREATS
* Few VC funded Online Startups eroding prices in market with negative cash flows and
discount funded strategies.
* B2B clients such as Hospital Lab management businesses not reliable as key position
changes in hospital may influence change of lab vendors OR the hospital may choose to
bring departments in-house.
* Low Barriers to entry
* Lack of regulation and licensing of Labs and lack mandatory quality norms hampers
opportunities for quality labs.
* Highly competitive market with presence of both local and national players everywhere
* Highly price sensitive market.
* Lack of awareness of quality parameters to differentiate between labs
STHRENGTHS
* Company Experience of 32 years with highly experienced staff retained
* Good Personal Brand Name of Dr A Lalchandani in Delhi/NCR
* Strong ties with many hospitals, doctors and nursing homes
* Customization of services for greater customer satisfaction
* Home Collection of Samples across Delhi/NCR
* Good customer follow-up in dormant Stages reminders for periodic health check-ups
* Good Online & Social Media presence in South Delhi currently
* Good Word of mouth from Doctors network about Dr Lalchandani labs Limited
* Nimble organization & management eager to adopt and change to respond to changing
needs of the market and customers.
* Personal Touch and active involvement of Founder and chief pathologist Dr Arjan
Lalchandani
* Management is young and enterprising and open to exploring all business opportunities
with an open mind.
* Highly Customer-centric and constantly thinking of improving user experience.
HUMAN RESOURCES
Dr Lalchandani Labs Limited is a player in the diagnostics sector. The diagnostics
business is a healthcare service delivery business, and thus the role of human resources
is pivotal in providing excellent quality service to the customers. The Companys business
has been constantly growing since the start of its business in the year 2017. Accordingly,
the human resources have to be commensurate with the size and growth of the business. As
per company HR policy, it has been employing suitable no. of employees from time to time
of requisite qualifications and experience and requisite expertise in respective fields.
The focus around enhancing the productivity of employees. The growth in business was
achieved with a marginal increase in workforce strength. This was achieved by active
redeployment of resources, introducing multi-taskers and job enlargements.
INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
The Company has an adequate internal control system in place with systems for
segregation of duties, access controls, and other relevant control practices.
Our board of Directors ensures efficient conduct of business and adheres to the
policies of the company thereby ensuring the maintenance of timely and reliable accounting
records and disclosures.
FORWARD-LOOKING STATEMENT
Except for the historical information contained herein, a statement in this discussion
that contains words or phrases such as ‘will, ‘would, ‘indicating,
‘expected to etc., and similar expressions or variations of such expressions may
constitute ‘forward-looking statements. These forward-looking statements involve a
number of risks, uncertainties and other factors that could cause actual results to differ
materially from those suggested by forward-looking statements.
These risks and uncertainty include but are not limited to, our ability to successfully
implement our strategy, future business plans, our growth and expansion in business, the
impact of technology implementation as well as other general risks applicable to the
business or industry. The company undertakes no obligation to update forward-looking
statements to reflect events or circumstances after the date thereof. These discussions
and analyses should be read in conjunction with the companys financial statements
included herein and notes thereto.
RECOVERING FROM COVID -19 PANDEMIC
While we have emerged stronger and bolder from the COVID-19 pandemic, we are acutely
aware that the pandemic has widened socioeconomic inequities. Our responsibility towards
our communities has increased manifold.
To deal with the unprecedented second wave, we have ramped up our response on multiple
fronts - our approach has been to address short-term emergency response as well as
contribute towards strengthening our public health infrastructure. Our overall healthcare
efforts have built capacity and run programs, closely collaborating with the public health
system, to serve geographies that have a population of over 150 million people.
The company is embarking on programs of transformation that would improve operational
efficiency and embrace agility at scale. Today, the pandemic has served to accelerate this
need to transform. Customers have accelerated their adoption of technology. They want
partners who can help them transform themselves rapidly, at speed. They need partners who
can be trusted. Who share the same business ethics and values. Also, increasingly they
want partners who can challenge the status quo, provide insights based on domain expertise
and can provide solutions for business outcomes.
+91-9892691696
